ВУЗ: Не указан

Категория: Не указан

Дисциплина: Не указана

Добавлен: 03.12.2023

Просмотров: 149

Скачиваний: 1

ВНИМАНИЕ! Если данный файл нарушает Ваши авторские права, то обязательно сообщите нам.

157 comparing slow-freezing versus vitrification to produce evidence for the development of global guidance. Hum Reprod Update. 2017;23(2):139–55.
181. Cobo A, Meseguer M, Remohí J, Pellicer A. Use of cryo-banked oocytes in an ovum donation programme: a prospective, randomized, controlled, clinical trial. Hum Reprod.
2010;25(9):2239–46.
182. Cobo A, Garrido N, Pellicer A, Remohí J. Six years’ experience in ovum donation using vitrified oocytes: report of cumulative outcomes, impact of storage time, and development of a predictive model for oocyte survival rate. Fertil Steril [Internet]. 2015;104(6):1426–8.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/26353081 183. Maheshwari A, Pandey S, Amalraj Raja E, Shetty A, Hamilton M, Bhattacharya S. Is frozen embryo transfer better for mothers and babies? Can cumulative meta-analysis provide a definitive answer? Hum Reprod Update. 2018;24(1):35–58.
184. Shi Q, Xie Y, Wang Y, Li S. Vitrification versus slow freezing for human ovarian tissue cryopreservation: a systematic review and meta-anlaysis. Sci Rep [Internet]. 2017;7(1):8538.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/28819292 185. Zhou X-H, Zhang D, Shi J, Wu Y-J. Comparison of vitrification and conventional slow freezing for cryopreservation of ovarian tissue with respect to the number of intact primordial follicles: A meta-analysis. Medicine (Baltimore) [Internet]. 2016;95(39):e4095. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27684791 186. Justice T, Christensen G. Sperm cryopreservation methods. Methods Mol Biol [Internet].
2013;927:209–15. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22992915 187. Levron J, Madgar I, Shefi S, Meirow D, Wiser A, Bider D, et al. IVF outcome with cryopreserved testicular sperm. Andrologia [Internet]. 2011;43(1):48–51. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21219382 188. Hovatta O, Foudila T, Siegberg R, Johansson K, von Smitten K, Reima I. Pregnancy resulting from intracytoplasmic injection of spermatozoa from a frozen-thawed testicular biopsy specimen. Hum Reprod [Internet]. 1996;11(11):2472–3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8981136 189. Vajta G, Rienzi L, Ubaldi FM. Open versus closed systems for vitrification of human oocytes and embryos. Reprod Biomed Online [Internet]. 2015;30(4):325–33. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25639657 190. Youm HS, Choi J-R, Oh D, Rho YH. Survival Rates in Closed and Open Vitrification for
Human Mature Oocyte Cryopreservation: A Meta-Analysis. Gynecol Obstet Invest
[Internet].
2018;83(3):268–74.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/29131105 191. Zegers-Hochschild F, Adamson GD, Dyer S, Racowsky C, de Mouzon J, Sokol R, et al. The
International Glossary on Infertility and Fertility Care, 2017. Fertil Steril. 2017;108(3):393–
406.
192. Гинтер ЕК, Пузырев ВП. Наследственные болезни. Национальное руководство.
Краткое издание. ГЭОТАР-Мед. Москва; 2017. 464 p.
193. Daughtry BL, Chavez SL. Chromosomal instability in mammalian pre-implantation embryos: potential causes, detection methods, and clinical consequences. Cell Tissue Res
[Internet].
2016;363(1):201–25.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/26590822 194. Minasi MG, Colasante A, Riccio T, Ruberti A, Casciani V, Scarselli F, et al. Correlation between aneuploidy, standard morphology evaluation and morphokinetic development in
1730 biopsied blastocysts: a consecutive case series study. Hum Reprod. 2016;31(10):2245–

158 54.
195. De Rycke M, Goossens V, Kokkali G, Meijer-Hoogeveen M, Coonen E, Moutou C. ESHRE
PGD Consortium data collection XIV-XV: cycles from January 2011 to December 2012 with pregnancy follow-up to October 2013. Hum Reprod [Internet]. 2017;32(10):1974–94.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/29117384 196. PGDIS position statement on chromosome mosaicism and preimplantation aneuploidy testing at the blastocyst stage. Chicago: PGDIS Newsletter, July 19, 2016.
197. Liss J, Chromik I, Szczyglińska J, Jagiełło M, Łukaszuk A, Łukaszuk K. Current methods for preimplantation genetic diagnosis. Ginekol Pol [Internet]. 2016;87(7):522–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27504946 198. Kane SC, Willats E, Bezerra Maia E Holanda Moura S, Hyett J, da Silva Costa F. Pre-
1   ...   14   15   16   17   18   19   20   21   22

Implantation Genetic Screening Techniques: Implications for Clinical Prenatal Diagnosis.
Fetal
Diagn
Ther
[Internet].
2016;40(4):241–54.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/27682145 199. Chen H-F, Chen S-U, Ma G-C, Hsieh S-T, Tsai H-D, Yang Y-S, et al. Preimplantation genetic diagnosis and screening: Current status and future challenges. J Formos Med Assoc
[Internet].
2018;117(2):94–100.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/28888353 200. Lu L, Lv B, Huang K, Xue Z, Zhu X, Fan G. Recent advances in preimplantation genetic diagnosis and screening. J Assist Reprod Genet [Internet]. 2016;33(9):1129–34. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27272212 201. Brezina PR, Anchan R, Kearns WG. Preimplantation genetic testing for aneuploidy: what technology should you use and what are the differences? J Assist Reprod Genet. 2016
Jul;33(7):823–32.
202. Рыжкова О, Кардымон О, Прохорчук Е. Руководство по интерпретации данных, полученных методами массового параллельного секвенирования (MPS). Медицинская генетика. 2017;16(7):4–17.
203. Deglincerti A, Croft GF, Pietila LN, Zernicka-Goetz M, Siggia ED, Brivanlou AH. Self- organization of the in vitro attached human embryo. Nature [Internet]. 2016;533(7602):251–
4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27144363 204. Practice Committee of American Society for Reproductive Medicine, Practice Committee of
Society for Assisted Reproductive Technology. Recommendations for gamete and embryo donation: a committee opinion. Fertil Steril [Internet]. 2013;99(1):47–62. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23095142 205. Ethics Committee of the American Society for Reproductive Medicine. Oocyte or embryo donation to women of advanced age: a committee opinion. Fertil Steril [Internet].
2013;100(2):337–40. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23472948 206. Ethics Committee of the American Society for Reproductive Medicine. Electronic address:
ASRM@asrm.org, Ethics Committee of the American Society for Reproductive Medicine.
Oocyte or embryo donation to women of advanced reproductive age: an Ethics Committee opinion.
Fertil
Steril
[Internet].
2016;106(5):e3--e7.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/27450186 207. Le Ray C, Scherier S, Anselem O, Marszalek A, Tsatsaris V, Cabrol D, et al. Association between oocyte donation and maternal and perinatal outcomes in women aged 43 years or older.
Hum
Reprod
[Internet].
2012;27(3):896–901.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/22252087 208. Practice Committee of the American Society for Reproductive Medicine and Practice

159
Committee of the Society for Assisted Reproductive Technology. Electronic address:
ASRM@asrm.org, Practice Committee of the American Society for Reproductive Medicine and Practice Committee of the Society for Assisted Reproductive Technology.
Recommendations for practices utilizing gestational carriers: a committee opinion. Fertil
Steril
[Internet].
2017;107(2):e3--e10.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/28069181 209. Сельков СА, Ярмолинская МИ. Эндометриоз как патология регуляторных механизмов.
Журнал акушерства и женских болезней. 2017;66(2):9–13.
210. Schifrin BS, Erez S, Moore JG. Teen-age endometriosis. Am J Obstet Gynecol [Internet].
1973;116(7):973–80. Available from: http://www.ncbi.nlm.nih.gov/pubmed/4718224 211. Wheeler JM. Epidemiology of endometriosis-associated infertility. J Reprod Med [Internet].
1989;34(1):41–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2704007 212. Giudice LC, Kao LC. Endometriosis. Lancet (London, England) [Internet]. 364(9447):1789–
99. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15541453 213. Fuentes A, Escalona J, Céspedes P, Espinoza A, Johnson MC. [Prevalence of endometriosis in 287 women undergoing surgical sterilization in Santiago Chile]. Rev Med Chil [Internet].
2014;142(1):16–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24861109 214. Macer ML, Taylor HS. Endometriosis and infertility: a review of the pathogenesis and treatment of endometriosis-associated infertility. Obstet Gynecol Clin North Am [Internet].
2012;39(4):535–49. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23182559 215. Bondza PK, Maheux R, Akoum A. Insights into endometriosis-associated endometrial dysfunctions: a review. Front Biosci (Elite Ed) [Internet]. 2009;1:415–28. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19482656 216. Saito H, Seino T, Kaneko T, Nakahara K, Toya M, Kurachi H. Endometriosis and oocyte quality. Gynecol Obstet Invest [Internet]. 2002;53 Suppl 1:46–51. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11834868 217. Mansour G, Aziz N, Sharma R, Falcone T, Goldberg J, Agarwal A. The impact of peritoneal fluid from healthy women and from women with endometriosis on sperm DNA and its relationship to the sperm deformity index. Fertil Steril [Internet]. 2009;92(1):61–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19409553 218. Mansour G, Sharma RK, Agarwal A, Falcone T. Endometriosis-induced alterations in mouse metaphase II oocyte microtubules and chromosomal alignment: a possible cause of infertility.
Fertil
Steril
[Internet].
2010;94(5):1894–9.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/19896655 219. Garrido N, Navarro J, García-Velasco J, Remoh J, Pellice A, Simón C. The endometrium versus embryonic quality in endometriosis-related infertility. Hum Reprod Update [Internet].
8(1):95–103. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11866246 220. Kissler S, Zangos S, Wiegratz I, Kohl J, Rody A, Gaetje R, et al. Utero-tubal sperm transport and its impairment in endometriosis and adenomyosis. Ann N Y Acad Sci [Internet].
2007;1101:38–48. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17344532 221. Barnhart K, Dunsmoor-Su R, Coutifaris C. Effect of endometriosis on in vitro fertilization.
Fertil
Steril
[Internet].
2002;77(6):1148–55.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/12057720 222. Oral E, Olive DL, Arici A. The peritoneal environment in endometriosis. Hum Reprod
Update
[Internet].
2(5):385–98.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/15717438 223. Defrère S, González-Ramos R, Lousse J-C, Colette S, Donnez O, Donnez J, et al. Insights


160 into iron and nuclear factor-kappa B (NF-kappaB) involvement in chronic inflammatory processes in peritoneal endometriosis. Histol Histopathol [Internet]. 2011;26(8):1083–92.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/21692040 224. Lousse J-C, Van Langendonckt A, Defrere S, Ramos RG, Colette S, Donnez J. Peritoneal endometriosis is an inflammatory disease. Front Biosci (Elite Ed) [Internet]. 2012;4:23–40.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/22201853 225. Duffy JMN, Arambage K, Correa FJS, Olive D, Farquhar C, Garry R, et al. Laparoscopic surgery for endometriosis. Cochrane database Syst Rev. 2014;(4):CD011031.
226. Ponce C, Torres M, Galleguillos C, Sovino H, Boric MA, Fuentes A, et al. Nuclear factor kappaB pathway and interleukin-6 are affected in eutopic endometrium of women with endometriosis.
Reproduction
[Internet].
2009;137(4):727–37.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/19129371 227. Yap C, Furness S, Farquhar C. Pre and post operative medical therapy for endometriosis surgery. Cochrane database Syst Rev. 2004;(3):CD003678.
228. Adamson GD, Pasta DJ. Endometriosis fertility index: the new, validated endometriosis staging system. Fertil Steril. 2010 Oct;94(5):1609–15.
229. Zikopoulos K, Kolibianakis EM, Devroey P. Ovarian stimulation for in vitro fertilization in patients with endometriosis. Acta Obstet Gynecol Scand [Internet]. 2004;83(7):651–5.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/15225190 230. Rickes D, Nickel I, Kropf S, Kleinstein J. Increased pregnancy rates after ultralong postoperative therapy with gonadotropin-releasing hormone analogs in patients with endometriosis.
Fertil
Steril
[Internet].
2002;78(4):757–62.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/12372452 231. Sallam HN, Garcia-Velasco JA, Dias S, Arici A. Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis. Cochrane database Syst Rev
[Internet].
2006;(1):CD004635.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/16437491 232. Gong F, Tang Y, Zhang H, Lu G. Modified super-long down-regulation protocol improved the outcome of in vitro fertilization-embryo transfer in infertile patients. Zhong Nan Da Xue
Xue
Bao
Yi
Xue
Ban
[Internet].
2009;34(3):185–9.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/19349670 233. van der Houwen LEE, Mijatovic V, Leemhuis E, Schats R, Heymans MW, Lambalk CB, et al. Efficacy and safety of IVF/ICSI in patients with severe endometriosis after long-term pituitary down-regulation. Reprod Biomed Online [Internet]. 2014;28(1):39–46. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24262434 234. Giudice LC, Evers LH, Healy DL, editors. Endometriosis: science and practice. London:
Wiley-Blackwell; 2012. 600 p.
235. Смольникова ВЮС. Изучение особенностей действия агонистов гонадотропин- рилизинг гормона - депо-декапептила и нафарелина в программе экстракорпорального оплодотворения и переноса эмбрионов в полость матки. Москва; 1995. 24 p.
236. Surrey ES, Silverberg KM, Surrey MW, Schoolcraft WB. Effect of prolonged gonadotropin- releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis. Fertil Steril [Internet]. 2002;78(4):699–704. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12372443 237. Kennedy S, Bergqvist A, Chapron C, D’Hooghe T, Dunselman G, Greb R, et al. ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod [Internet].
2005;20(10):2698–704. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15980014

161 238. Leung AS, Dahan MH. The benefits of other treatments than in vitro fertilization to aid conception in minimal and mild endometriosis. Minerva Ginecol [Internet]. 2016;68(6):675–
86. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27077394 239. Boujenah J, Santulli P, Mathieu-d’Argent E, Decanter C, Chauffour C, Poncelet P. [First line management without IVF of infertility related to endometriosis: Result of medical therapy?
Results of ovarian superovulation? Results of intrauterine insemination? CNGOF-HAS
Endometriosis Guidelines]. Gynecol Obstet Fertil Senol [Internet]. 2018;46(3):331–7.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/29551300 240. Geisler ME, Ledwidge M, Bermingham M, McAuliffe M, McMenamin MB, Waterstone JJ.
Intrauterine insemination-No more Mr. N.I.C.E. guy? Eur J Obstet Gynecol Reprod Biol
[Internet]. 2017;210:342–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28122315 241. Siristatidis CS, Gibreel A, Basios G, Maheshwari A, Bhattacharya S. Gonadotrophin- releasing hormone agonist protocols for pituitary suppression in assisted reproduction.
Cochrane database Syst Rev. 2015;(11):CD006919.
242. Bastu E, Yasa C, Dural O, Mutlu MF, Celik C, Ugurlucan FG, et al. Comparison of ovulation induction protocols after endometrioma resection. JSLS J Soc Laparoendosc Surg [Internet].
18(3). Available from: http://www.ncbi.nlm.nih.gov/pubmed/25392665 243. Pabuccu R, Onalan G, Kaya C. GnRH agonist and antagonist protocols for stage I-II endometriosis and endometrioma in in vitro fertilization/intracytoplasmic sperm injection cycles.
Fertil
Steril
[Internet].
2007;88(4):832–9.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/17428479 244. Kitajima M, Khan KN, Harada A, Taniguchi K, Inoue T, Kaneuchi M, et al. Association between ovarian endometrioma and ovarian reserve. Front Biosci (Elite Ed) [Internet].
2018;10:92–102. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28930606 245. Yanushpolsky EH, Best CL, Jackson K V, Clarke RN, Barbieri RL, Hornstein MD. Effects of endometriomas on ooccyte quality, embryo quality, and pregnancy rates in in vitro fertilization cycles: a prospective, case-controlled study. J Assist Reprod Genet [Internet].
1998;15(4):193–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9565848 246. Matsuzaki S, Schubert B. Oxidative stress status in normal ovarian cortex surrounding ovarian endometriosis. Fertil Steril. 2010 May;93(7):2431–2.
247. Brosens I. Endometriosis and the outcome of in vitro fertilization. Fertil Steril [Internet].
2004;81(5):1198–200. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15136075 248. Geber S, Ferreira DP, Spyer Prates LFV, Sales L, Sampaio M. Effects of previous ovarian surgery for endometriosis on the outcome of assisted reproduction treatment. Reprod Biomed
Online
[Internet].
5(2):162–6.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/12419041 249. Muzii L, Di Tucci C, Di Feliciantonio M, Marchetti C, Perniola G, Panici PB. The effect of surgery for endometrioma on ovarian reserve evaluated by antral follicle count: a systematic review and meta-analysis. Hum Reprod. 2014 Oct;29(10):2190–8.
250. Raffi F, Metwally M, Amer S. The impact of excision of ovarian endometrioma on ovarian reserve: a systematic review and meta-analysis. J Clin Endocrinol Metab [Internet].
2012;97(9):3146–54. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22723324 251. Garcia-Velasco JA, Mahutte NG, Corona J, Zúñiga V, Gilés J, Arici A, et al. Removal of endometriomas before in vitro fertilization does not improve fertility outcomes: a matched, case-control study. Fertil Steril [Internet]. 2004;81(5):1194–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15136074 252. Somigliana E, Arnoldi M, Benaglia L, Iemmello R, Nicolosi AE, Ragni G. IVF-ICSI


162 outcome in women operated on for bilateral endometriomas. Hum Reprod [Internet].
2008;23(7):1526–30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18441346 253. Ruiz Anguas J, Carballo Mondragón E, Anta Jaen E, Durán Monterrosas L, Kably Ambe A.
[Clinical implication and frequency of the incidental finding of endometriosis during oocyte retrieval].
Ginecol
Obstet
Mex
[Internet].
2007;75(3):121–6.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/17547085 254. Cirpan T, Akercan F, Tavmergen Goker EN, Ozyurek E, Levi R, Tavmergen E.
Laparoscopic resection or sonography-guided vaginal aspiration of endometriomas prior to
ICSI-ET does not worsen treatment outcomes. Clin Exp Obstet Gynecol [Internet].
2007;34(4):215–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18225681 255. Demirol A, Guven S, Baykal C, Gurgan T. Effect of endometrioma cystectomy on IVF outcome: a prospective randomized study. Reprod Biomed Online [Internet].
2006;12(5):639–43. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16790114 256. Yu H-T, Huang H-Y, Tseng H-J, Wang C-J, Lee C-L, Soong Y-K. Bilaterality of ovarian endometriomas does not affect the outcome of in vitro fertilization/intracytoplasmic sperm injection in infertile women after laparoscopic cystectomy. Biomed J [Internet].
2017;40(5):295–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29179885 257. Hamdan M, Dunselman G, Li TC, Cheong Y. The impact of endometrioma on IVF/ICSI outcomes: a systematic review and meta-analysis. Hum Reprod Update [Internet]. 21(6):809–
25. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26168799 258. Leone Roberti Maggiore U, Gupta JK, Ferrero S. Treatment of endometrioma for improving fertility. Eur J Obstet Gynecol Reprod Biol [Internet]. 2017;209:81–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26968428 259. Jadoul P, Kitajima M, Donnez O, Squifflet J, Donnez J. Surgical treatment of ovarian endometriomas: state of the art? Fertil Steril [Internet]. 2012;98(3):556–63. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22763094 260. Younes G, Tulandi T. Effects of adenomyosis on in vitro fertilization treatment outcomes: a meta-analysis.
Fertil
Steril
[Internet].
2017;108(3):483--490.e3.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/28865548 261. Mavrelos D, Holland TK, O’Donovan O, Khalil M, Ploumpidis G, Jurkovic D, et al. The impact of adenomyosis on the outcome of IVF-embryo transfer. Reprod Biomed Online
[Internet].
2017;35(5):549–54.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/28802706 262. Dueholm M. Uterine adenomyosis and infertility, review of reproductive outcome after in vitro fertilization and surgery. Acta Obstet Gynecol Scand [Internet]. 2017;96(6):715–26.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/28556124 263. Vercellini P, Consonni D, Dridi D, Bracco B, Frattaruolo MP, Somigliana E. Uterine adenomyosis and in vitro fertilization outcome: a systematic review and meta-analysis. Hum
Reprod. 2014;29(5):964–77.
264. Soave I, Wenger J-M, Pluchino N, Marci R. Treatment options and reproductive outcome for adenomyosis-associated infertility. Curr Med Res Opin [Internet]. 2018;34(5):839–49.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/29046066 265. Назаренко ТА. Стимуляция функции яичников. М.: МЕДпресс-информ; 2015. 288 p.
266. Wang B, Kong N, Liu J-Y, Zhang N-Y, Zhu Y-C, Zhou J-J. [Repeated superovulation induction after failure in previous IVF-ET cycles with the ultra-long protocol: Analysis of outcomes of clinical pregnancy]. Zhonghua Nan Ke Xue [Internet]. 2017;23(12):1099–102.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/29738181

163 267. Jeve YB, Bhandari HM. Effective treatment protocol for poor ovarian response: A systematic review and meta-analysis. J Hum Reprod Sci [Internet]. 9(2):70–81. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27382230 268. Youssef MA-F, van Wely M, Mochtar M, Fouda UM, Eldaly A, El Abidin EZ, et al. Low dosing of gonadotropins in in vitro fertilization cycles for women with poor ovarian reserve: systematic review and meta-analysis. Fertil Steril [Internet]. 2018;109(2):289–301. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29317127 269. Baker VL, Brown MB, Luke B, Smith GW, Ireland JJ. Gonadotropin dose is negatively correlated with live birth rate: analysis of more than 650,000 assisted reproductive technology cycles.
1   ...   14   15   16   17   18   19   20   21   22

Fertil
Steril
[Internet].
2015;104(5):1145.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/26297646 270. Fan W, Li S, Chen Q, Huang Z, Ma Q, Wang Y. Recombinant Luteinizing Hormone supplementation in poor responders undergoing IVF: a systematic review and meta-analysis.
Gynecol
Endocrinol
[Internet].
2013;29(4):278–84.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/23347045 271. Lehert P, Kolibianakis EM, Venetis CA, Schertz J, Saunders H, Arriagada P, et al.
Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis. Reprod Biol Endocrinol [Internet].
2014;12:17. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24555766 272. Youssef MA, van Wely M, Al-Inany H, Madani T, Jahangiri N, Khodabakhshi S, et al. A mild ovarian stimulation strategy in women with poor ovarian reserve undergoing IVF: a multicenter randomized non-inferiority trial. Hum Reprod. 2017;32(1):112–8.
273. Ragni G, Levi-Setti PE, Fadini R, Brigante C, Scarduelli C, Alagna F, et al. Clomiphene citrate versus high doses of gonadotropins for in vitro fertilisation in women with compromised ovarian reserve: a randomised controlled non-inferiority trial. Reprod Biol
Endocrinol
[Internet].
2012;10:114.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/23249758 274. Practice Committee of the American Society for Reproductive Medicine. Electronic address:
ASRM@asrm.org. Comparison of pregnancy rates for poor responders using IVF with mild ovarian stimulation versus conventional IVF: a guideline. Fertil Steril [Internet].
2018;109(6):993–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29935660 275. Polyzos NP, Blockeel C, Verpoest W, De Vos M, Stoop D, Vloeberghs V, et al. Live birth rates following natural cycle IVF in women with poor ovarian response according to the
Bologna criteria. Hum Reprod. 2012;27(12):3481–6.
276. Reynolds KA, Omurtag KR, Jimenez PT, Rhee JS, Tuuli MG, Jungheim ES. Cycle cancellation and pregnancy after luteal estradiol priming in women defined as poor responders: a systematic review and meta-analysis.
Hum
Reprod
[Internet].
2013;28(11):2981–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23887073 277. Vaiarelli A, Cimadomo D, Trabucco E, Vallefuoco R, Buffo L, Dusi L, et al. Double
Stimulation in the Same Ovarian Cycle (DuoStim) to Maximize the Number of Oocytes
Retrieved From Poor Prognosis Patients: A Multicenter Experience and SWOT Analysis.
Front
Endocrinol
(Lausanne)
[Internet].
2018;9:317.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/29963011 278. Humaidan P, Alviggi C, Fischer R, Esteves SC. The novel POSEIDON stratification of “Low prognosis patients in Assisted Reproductive Technology” and its proposed marker of successful outcome.
F1000Research
[Internet].
2016;5:2911.
Available from:

164 http://www.ncbi.nlm.nih.gov/pubmed/28232864 279. Poseidon Group (Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number),
Alviggi C, Andersen CY, Buehler K, Conforti A, De Placido G, et al. A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept. Fertil Steril [Internet]. 2016;105(6):1452–3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26921622 280. Cobo A, Garrido N, Crespo J, José R, Pellicer A. Accumulation of oocytes: a new strategy for managing low-responder patients. Reprod Biomed Online [Internet]. 2012;24(4):424–32.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/22386762 281. Forman EJ, Hong KH, Ferry KM, Tao X, Taylor D, Levy B, et al. In vitro fertilization with single euploid blastocyst transfer: a randomized controlled trial. Fertil Steril. 2013
Jul;100(1):100–7.e1.
282. Galliano D, Bellver J, Díaz-García C, Simón C, Pellicer A. ART and uterine pathology: how relevant is the maternal side for implantation? Hum Reprod Update [Internet]. 21(1):13–38.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/25155826 283. Kremer C, Duffy S, Moroney M. Patient satisfaction with outpatient hysteroscopy versus day case hysteroscopy: randomised controlled trial. BMJ [Internet]. 2000;320(7230):279–82.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/10650023 284. Guida M, Pellicano M, Zullo F, Acunzo G, Lavitola G, Palomba S, et al. Outpatient operative hysteroscopy with bipolar electrode: a prospective multicentre randomized study between local anaesthesia and conscious sedation. Hum Reprod [Internet]. 2003;18(4):840–3.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/12660281 285. Pellicano M, Guida M, Zullo F, Lavitola G, Cirillo D, Nappi C. Carbon dioxide versus normal saline as a uterine distension medium for diagnostic vaginoscopic hysteroscopy in infertile patients: a prospective, randomized, multicenter study. Fertil Steril [Internet].
2003;79(2):418–21. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12568856 286. AAGL Practice Report: Practice Guidelines for the Diagnosis and Management of
Submucous Leiomyomas. J Minim Invasive Gynecol [Internet]. 2012;19(2):152–71.
Available from: http://linkinghub.elsevier.com/retrieve/pii/S1553465011011897 287. Marret H, Fritel X, Ouldamer L, Bendifallah S, Brun J-L, De Jesus I, et al. Therapeutic management of uterine fibroid tumors: updated French guidelines. Eur J Obstet Gynecol
Reprod
Biol
[Internet].
2012;165(2):156–64.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/22939241 288. Klatsky PC, Tran ND, Caughey AB, Fujimoto VY. Fibroids and reproductive outcomes: a systematic literature review from conception to delivery. Am J Obstet Gynecol [Internet].
2008;198(4):357–66. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18395031 289. Коган
ИЮ, Беженарь ВФ, Долинский АК, Чмаро МГ. Эффективность вспомогательных методов репродукции у больных с миомой матки. Журнал акушерства и женских болезней. 2012;(4):113–8.
290. Seki H, Takizawa Y, Sodemoto T. Epidural analgesia for painful myomas refractory to medical therapy during pregnancy. Int J Gynaecol Obstet [Internet]. 2003;83(3):303–4.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/14643043 291. Wiesenfeld HC, Hillier SL, Meyn LA, Amortegui AJ, Sweet RL. Subclinical pelvic inflammatory disease and infertility. Obstet Gynecol [Internet]. 2012;120(1):37–43.
Available from: http://www.ncbi.nlm.nih.gov/pubmed/22678036 292. Тапильскя
НИ, Карпеев СА, Гайдуков СН. Обоснование эффективности антибактериальной терапии в лечении хронической воспалительной болезни матки.